摘要
Background and Purpose: Atherosclerosis induced by cyclosporine A (CsA), an inhibitor of the calcineurin/nuclear factor of activated T cells (NFAT) pathway, is a major concern after organ transplantation. However, the atherosclerotic mechanisms of CsA remain obscure. We previously demonstrated that calcineurin/NFAT signalling inhibition contributes to atherogenesis via suppressing microRNA-204 (miR-204) transcription. We therefore hypothesised that miR-204 is involved in the development of CsA-induced atherosclerosis.Experimental Approach: ApoE(-/-) mice with macrophage-miR-204 overexpression were generated to determine the effects of miR-204 on CsA-induced atherosclerosis. Luciferase reporter assays and chromatin immunoprecipitation sequencing were performed to explore the targets mediating miR-204 effects.Key Results: CsA alone did not significantly affect atherosclerotic lesions or serum lipid levels. However, it exacerbated high-fat diet-induced atherosclerosis and hyperlipidemia in C57BL/6J and ApoE(-/-) mice, respectively. miR-204 levels decreased in circulating monocytes and plaque lesions during CsA-induced atherosclerosis. The upregulation of miR-204 in macrophages inhibited CsA-induced atherosclerotic plaque formation but did not affect serum lipid levels. miR-204 limited the CsA-induced foam cell formation by reducing the expression of the scavenger receptors SR-BII and CD36. SR-BII was post-transcriptionally regulated by mature miR-204-5p via 3 ' -UTR targeting. Additionally, nuclear-localised miR-204-3p prevented the CsA-induced binding of Ago2 to the CD36 promoter, suppressing CD36 transcription. SR-BII or CD36 expression restoration dampened the beneficial effects of miR-204 on CsA-induced atherosclerosis.Conclusion and Implications: Macrophage miR-204 ameliorates CsA-induced atherosclerosis, suggesting that miR-204 may be a potential target for the prevention and treatment of CsA-related atherosclerotic side effects.
学科与关键词
- Macrophage NFAT c3 prevents foam cell formation and atherosclerosis: evidence and mechanismsLiu, Xiu; Guo, Jia-Wei; Lin, Xiao-Chun; Tuo, Yong-Hua; Peng, Wan-Li; He, Su-Yue; Li, Zhao-Qiang; Ye, Yan-Chen; Yu, Jie; Zhang, Fei-Ran; Ma, Ming-Ming; Shang, Jin-Yan; Lv, Xiao-Fei; Zhou, An-Dong; Ouyang, Ying; Wang, Cheng; Pang, Rui-Ping; Sun, Jian-Xin; Ou, Jing-Song*; Zhou, Jia-Guo*; Liang, Si-Jia*European Heart Journal, 2021, 42(47): 4847-+.被引 42
- miR-320a Targeting RGS5 Aggravates Atherosclerosis by Promoting Migration and Proliferation of ox-LDL-Stimulated Vascular Smooth Muscle CellsZhang, Chi; Wang, Xun*Journal of Cardiovascular Pharmacology, 2022, 80(1): 110-117.被引 5
- MicroRNA-98 inhibition accelerates the development of atherosclerosis via regulation of dysfunction of endothelial cellYu, Huai; Cao, Hui; Yu, HangClinical and Experimental Hypertension, 2023, 45(1): 2206068.被引 3
